# Actuate Therapeutics, Inc.: filings

ACTU · Nasdaq · CIK 1652935 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/actu.md) · [Financials](/companies/actu/financials.md) · [Filings](/companies/actu/filings.md) · [Insiders](/companies/actu/insiders.md)

## Reports and events: 46 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 41, 8-K 21, CORRESP 21, 3 13, D 11, UPLOAD 9, 10-Q 7, S-1/A 7, EFFECT 5, FWP 5, 424B5 4, DRSLTR 4, S-1 4, 4/A 3, DEFA14A 3, DRS 3, DRS/A 3, S-8 3, 10-K 2, 424B3 2, D/A 2, DEF 14A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 144 1, 424B4 1, 8-A12B 1, 8-A12B/A 1, ARS 1, CERT 1, POS EX 1, S-3 1, SC 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:05 ET | [8-K](/filings/0001683168-26-008193.md) | 3.01 Delisting notice | 0001683168-26-008193 |
| 2026-10-28 | 17:17 ET | [8-K](/filings/0001683168-26-008143.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-008143 |
| 2026-10-19 | 08:00 ET | [S-1/A](/filings/0001683168-26-007941.md) | Registration statement, amended | 0001683168-26-007941 |
| 2026-10-14 | 08:01 ET | [S-1/A](/filings/0001683168-26-007832.md) | Registration statement, amended | 0001683168-26-007832 |
| 2026-10-06 | 16:52 ET | [S-1](/filings/0001683168-26-007661.md) | Registration statement | 0001683168-26-007661 |
| 2026-08-14 | 16:05 ET | [10-Q](/filings/0001683168-26-006472.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006472 |
| 2026-07-17 | 16:30 ET | [8-K](/filings/0001683168-26-005616.md) | 3.01 Delisting notice | 0001683168-26-005616 |
| 2026-05-22 | 16:43 ET | [8-K](/filings/0001683168-26-004268.md) | 5.07 Shareholder vote results | 0001683168-26-004268 |
| 2026-05-14 | 16:01 ET | [10-Q](/filings/0001683168-26-003909.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003909 |
| 2026-05-11 | 17:27 ET | [8-K](/filings/0001683168-26-003684.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-003684 |
| 2026-05-06 | 09:45 ET | [8-K](/filings/0001683168-26-003515.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-003515 |
| 2026-04-06 | 16:06 ET | [DEF 14A](/filings/0001683168-26-002691.md) | Proxy statement, period 2026-05-21 | 0001683168-26-002691 |
| 2026-03-26 | 16:00 ET | [10-K](/filings/0001683168-26-002257.md) | Annual report, period 2025-12-31 | 0001683168-26-002257 |
| 2026-01-12 | 16:00 ET | [8-K](/filings/0001683168-26-000217.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-000217 |
| 2025-11-28 | 17:21 ET | [8-K](/filings/0001683168-25-008732.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-008732 |
| 2025-11-21 | 16:30 ET | [8-K](/filings/0001683168-25-008618.md) | 8.01 Other events | 0001683168-25-008618 |
| 2025-11-13 | 16:00 ET | [10-Q](/filings/0001683168-25-008323.md) | Quarterly report, period 2025-09-30 | 0001683168-25-008323 |
| 2025-09-10 | 17:11 ET | [8-K](/filings/0001683168-25-006831.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-006831 |
| 2025-08-14 | 16:01 ET | [10-Q](/filings/0001683168-25-006159.md) | Quarterly report, period 2025-06-30 | 0001683168-25-006159 |
| 2025-07-25 | 16:00 ET | [S-1](/filings/0001683168-25-005402.md) | Registration statement | 0001683168-25-005402 |
| 2025-06-30 | 12:08 ET | [SCHEDULE 13D/A](/filings/0001104659-25-063957.md) | Ownership report, active investor, amended | 0001104659-25-063957 |
| 2025-06-26 | 08:11 ET | [8-K](/filings/0001683168-25-004766.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-25-004766 |
| 2025-06-05 | 14:57 ET | [8-K](/filings/0001683168-25-004258.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-004258 |
| 2025-06-02 | 07:40 ET | [8-K](/filings/0001683168-25-004117.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-004117 |
| 2025-05-27 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-25-052987.md) | Ownership report, active investor, amended | 0001104659-25-052987 |
| 2025-05-23 | 16:10 ET | [8-K](/filings/0001683168-25-003995.md) | 5.07 Shareholder vote results | 0001683168-25-003995 |
| 2025-05-15 | 16:08 ET | [10-Q](/filings/0001683168-25-003705.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003705 |
| 2025-05-06 | 08:09 ET | [8-K](/filings/0001683168-25-003163.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-003163 |
| 2025-04-08 | 16:15 ET | [DEF 14A](/filings/0001683168-25-002344.md) | Proxy statement, period 2025-05-22 | 0001683168-25-002344 |
| 2025-03-28 | 06:23 ET | [S-1](/filings/0001683168-25-001948.md) | Registration statement | 0001683168-25-001948 |
| 2025-03-28 | 06:00 ET | [8-K](/filings/0001683168-25-001945.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-25-001945 |
| 2025-03-13 | 16:30 ET | [10-K](/filings/0001683168-25-001581.md) | Annual report, period 2024-12-31 | 0001683168-25-001581 |
| 2025-02-07 | 16:30 ET | [8-K](/filings/0001683168-25-000826.md) | 8.01 Other events | 0001683168-25-000826 |
| 2024-12-17 | 16:57 ET | [8-K](/filings/0001683168-24-008794.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-008794 |
| 2024-11-13 | 16:00 ET | [10-Q](/filings/0001683168-24-007971.md) | Quarterly report, period 2024-09-30 | 0001683168-24-007971 |
| 2024-11-12 | 08:50 ET | [8-K](/filings/0001683168-24-007857.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-007857 |
| 2024-09-24 | 16:05 ET | [10-Q](/filings/0001683168-24-006623.md) | Quarterly report, period 2024-06-30 | 0001683168-24-006623 |
| 2024-08-19 | 20:59 ET | [SC 13D](/filings/0001104659-24-090990.md) | Ownership report, active investor | 0001104659-24-090990 |
| 2024-08-19 | 17:25 ET | [8-K](/filings/0001683168-24-005919.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-24-005919 |
| 2024-08-14 | 16:37 ET | [8-K](/filings/0001104659-24-089693.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-089693 |
| 2024-07-23 | 06:01 ET | [S-1/A](/filings/0001104659-24-081626.md) | Registration statement, amended | 0001104659-24-081626 |
| 2024-07-19 | 07:58 ET | [S-1/A](/filings/0001104659-24-081008.md) | Registration statement, amended | 0001104659-24-081008 |
| 2024-07-16 | 14:41 ET | [S-1/A](/filings/0001104659-24-080179.md) | Registration statement, amended | 0001104659-24-080179 |
| 2024-06-21 | 12:47 ET | [S-1/A](/filings/0001104659-24-073848.md) | Registration statement, amended | 0001104659-24-073848 |
| 2024-06-11 | 07:01 ET | [S-1/A](/filings/0001104659-24-070185.md) | Registration statement, amended | 0001104659-24-070185 |
| 2024-05-24 | 16:59 ET | [S-1](/filings/0001104659-24-065172.md) | Registration statement | 0001104659-24-065172 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:14 ET. No prices; not investment advice.